NCT00841217View on ClinicalTrials.gov

Regulation of Lipoprotein Transport in Metabolic Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

August 31, 2005

Study Completion Date

December 31, 2008

Conditions
ObesityLipid DisordersCardiovascular Disease
Interventions
DRUG

GW501516

2.5mg/day

DRUG

placebo pill

Trial Locations (1)

6000

University of Western Australia, Perth

All Listed Sponsors
collaborator

National Heart Foundation, Australia

OTHER

lead

The University of Western Australia

OTHER

NCT00841217 - Regulation of Lipoprotein Transport in Metabolic Syndrome | Biotech Hunter | Biotech Hunter